Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suneil Jain

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Nature Reviews. Urology|July 24, 2020
The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needsMichelle M Kouspou, Jenna E Fong, Nadine Brew, et al.
NIHR Open Research|October 25, 2023
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trialPaul Gravestock, Emma Clark, Miranda Morton, et al.
Cancers|October 2, 2020
Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate CancerCharles M Haughey, Debayan Mukherjee, Rebecca E Steele, et al.
International Journal of Nanomedicine|June 16, 2012
Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticlesJonathan A Coulter, Suneil Jain, Karl T Butterworth, et al.
NAR Cancer|August 4, 2020
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinomaChris W D Armstrong, Jonathan A Coulter, Chee Wee Ong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 22, 2023
Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: Results from the NI-HEART studyGerard M Walls, John O'Connor, Mark Harbinson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 13, 2024
Associations of Prostate Tumor Immune Landscape with Vigorous Physical Activity and Prostate Cancer ProgressionLanshan Huang, Sarah J Winter, Linnea T Olsson, et al.
Clinical and Translational Radiation Oncology|February 24, 2026
PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRTAngela Pathmanathan, Suneil Jain, John Staffurth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2023
A pulmonary vein atlas for radiotherapy planningGerard M Walls, Conor McCann, Peter Ball, et al.
BMJ Open|December 26, 2024
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Sophie Alexander, Sarah R Brown, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Nature Reviews. Urology|July 24, 2020
The Movember Prostate Cancer Landscape Analysis: an assessment of unmet research needsMichelle M Kouspou, Jenna E Fong, Nadine Brew, et al.
NIHR Open Research|October 25, 2023
Using the AR-V7 biomarker to determine treatment in metastatic castrate resistant prostate cancer, a feasibility randomised control trial, conclusions from the VARIANT trialPaul Gravestock, Emma Clark, Miranda Morton, et al.
Cancers|October 2, 2020
Investigating Radiotherapy Response in a Novel Syngeneic Model of Prostate CancerCharles M Haughey, Debayan Mukherjee, Rebecca E Steele, et al.
International Journal of Nanomedicine|June 16, 2012
Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticlesJonathan A Coulter, Suneil Jain, Karl T Butterworth, et al.
NAR Cancer|August 4, 2020
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinomaChris W D Armstrong, Jonathan A Coulter, Chee Wee Ong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 22, 2023
Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: Results from the NI-HEART studyGerard M Walls, John O'Connor, Mark Harbinson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 13, 2024
Associations of Prostate Tumor Immune Landscape with Vigorous Physical Activity and Prostate Cancer ProgressionLanshan Huang, Sarah J Winter, Linnea T Olsson, et al.
Clinical and Translational Radiation Oncology|February 24, 2026
PACE-NODES: A phase III randomised trial of 5 fraction prostate stereotactic body radiotherapy (SBRT) versus 5 fraction prostate and pelvic nodal SBRTAngela Pathmanathan, Suneil Jain, John Staffurth, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 27, 2023
A pulmonary vein atlas for radiotherapy planningGerard M Walls, Conor McCann, Peter Ball, et al.
BMJ Open|December 26, 2024
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Sophie Alexander, Sarah R Brown, et al.
Pageof 10